2006•TherapyRequires access
Etanercept and methotrexate for the treatment of rheumatoid arthritis
Nobuyuki Miyasaka
Open publisher page 0 citations
Abstract
A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.